Aquestive Therapeutics Inc (AQST)

Stock-Based Compensation

$2.90M

Quarterly · Period ending: · USD

AQST logo

AQST Stock-Based Compensation

Latest reported$2.90M
AQST Quarterly Stock-Based Comp ($0.00 → $2.90M)
High-resolution chart · PNG

AQST stock-based compensation history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Aquestive Therapeutics Inc Stock-Based Compensation — Quarterly (USD)
Period endingStock-Based Compensation (USD)
2,895,000
2,318,000
1,376,000
2,777,000
1,884,000
1,587,000
2,403,000
1,577,000
1,539,000
1,580,000
940,000
774,000
631,000
344,000
714,000
535,000
2,219,000
913,000
1,691,000
1,900,000
1,721,000
1,507,000
0
1,765,000
1,765,000
1,860,000
0
1,869,000
1,810,000
1,520,000
1,399,000
1,236,000
27,305,000
0
0
0
0
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.